CDH13 promoter region is specifically methylated in poorly differentiated colorectal cancer

British Journal of Cancer

Volumn 90, Issue 5, 2004, Pages 1030-1033

  Hibi, K ^a   Nakayama, H ^a   Kodera, Y ^a   Ito, K ^a   Akiyama, S ^a   Nakao, A ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

CDH13; Colorectal cancer; Methylation specific PCR

Indexed keywords

CADHERIN; CADHERIN H; CADHERIN T; UNCLASSIFIED DRUG;

ARTICLE; CARCINOMA CELL; CDH13 GENE; CELL ADHESION; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE EXPRESSION; GENE INACTIVATION; HISTOLOGY; HUMAN; HUMAN TISSUE; METHYLATION; PATHOLOGY; PRIORITY JOURNAL; PROMOTER REGION; STATISTICAL SIGNIFICANCE;

CADHERINS; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CELL DIFFERENTIATION; COLORECTAL NEOPLASMS; DNA; DNA METHYLATION; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; LYMPHATIC METASTASIS; MALE; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SULFITES; TUMOR CELLS, CULTURED;

EID: 1942424829     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601647     Document Type: Article

References (19)

1. Baker SJ, Markowitz S, Fearon ER, Willson JK, Vogelstein B (1990) Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249: 912-915
2. Bos JL, Fearon ER, Hamilton SR, Verlaan-de Vries M, van Boom JH, van der Eb AJ, Vogelstein B (1987) Prevalence of ras gene mutations in human colorectal cancers. Nature 327: 293-297
3. Greenlee RT, Murray T, Bolden S, Wingo PA (2000) Cancer statistics, 2000. CA Cancer J Clin 50: 7-33
4. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB (1996) Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93: 9821-9826
5. Hibi K, Nakamura H, Hirai A, Fujikake Y, Kasai Y, Akiyama S, Ito K, Takagi H (1996) Loss of H19 imprinting in esophageal cancer. Cancer Res 56: 480-482
6. Hibi K, Nakayama H, Koike M, Kasai Y, Ito K, Akiyama S, Nakao A (2002) Colorectal cancers with both p16 and p14 methylation show invasive characteristics. Jpn J Cancer Res 93: 883-887
7. Hibi K, Taguchi M, Nakamura H, Hirai A, Fujikake Y, Matsui T, Kasai Y, Akiyama S, Ito K, Takagi H (1997) Alternative splicing of the FHIT gene in colorectal cancer. Jpn J Cancer Res 88: 385-388
8. Hibi K, Taguchi M, Nakayama H, Takase T, Kasai Y, Ito K, Akiyama S, Nakao A (2001) Molecular detection of p16 promoter methylation in the serum of patients with esophageal squamous cell carcinoma. Clin Cancer Res 7: 3135-3138
9. Hibi K, Takahashi T, Sekido Y, Ueda R, Hida T, Ariyoshi Y, Takagi H, Takahashi T (1991) Coexpression of the stem cell factor and the c-kit genes in small-cell lung cancer. Oncogene 6: 2291-2296
10. Kanazawa T, Watanabe T, Kazama S, Tada T, Koketsu S, Nagawa H (2002) Poorly differentiated adenocarcinoma and mucinous carcinoma of the colon and rectum show higher rates of loss of heterozygosity and loss of E-Cadherin expression due to methylation of promoter region. Int J Cancer 102: 225-229
11. Nishisho I, Nakamura Y, Miyoshi Y, Mild Y, Ando H, Horii A, Koyama K, Utsunomiya J, Baba S, Hedge P (1991) Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 253: 665-669
12. Risio M, Reato G, di Celle PF, Fizzotti M, Rossini FP, Foa R (1996) Microsatellite instability is associated with the histological features of the tumor in nonfamilial colorectal cancer. Cancer Res 56: 5470-5474
13. Sato M, Mori Y, Sakurada A., Fujimura S, Horii A (1998) The H-cadherin (CDH13) gene is inactivated in human lung cancer. Hum Genet 103: 96-101
14. Takeichi M (1991) Cadherin cell adhesion receptors as a morphogenetic regulator. Science 251: 1451-1455
15. Tamura G, Yin J, Wang S, Fleisher AS, Zou T, Abraham JM, Kong D, Smolinski KN, Wilson KT, James SP, Silverberg SG, Nishizuka S, Terashima M, Motoyama T, Meltzer SJ (2000) E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas. J Natl Cancer Inst 92: 569-573
16. Toyooka S, Toyooka KO, Harada K, Miyajima K, Makarla P, Sathyanarayama UG, Yin J, Sato F, Shivapurkar N, Meltzer SJ, Gazdar AF (2002) Aberrant methylation of the CDH13 (H-cadherin) promoter region in colorectal cancers and adenomas. Cancer Res 62: 3382-3386
17. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL (1988) Genetic alterations during colorectal-tumor development. N Engl J Med 319: 525-532
18. Yamazaki T, Hibi K, Takase T, Tezel E, Nakayama H, Kasai Y, Ito K, Akiyama S, Nagasaka T, Nakao A (2002) PGP9.5 as a marker for invasive colorectal cancer. Clin Cancer Res 8: 192-195
19. Zheng S, Chen P, McMillan A, Lafuente A, Lafuente MJ, Ballesta A, Trias M, Wiencke JK (2001) Correlations of partial and extensive methylation at the p14ARF locus with reduced mRNA expression in colorectal cancer cell lines and clinicopathological features in primary tumors. Carcinogenesis 21: 2057-2064